Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees

被引：0
|
作者：
Huang, Jennifer Jing
Liang, Emily C.
Albittar, Aya
Portuguese, Andrew Jay
Wuliji, Natalie
Torkelson, Aiko
Kirchmeier, Delaney
Chutnik, Abigail
Pender, Barbara
Shadman, Mazyar
Hirayama, Alexandre V.
Till, Brian G.
Kimble, Erik Lesley
Iovino, Lorenzo
Chapuis, Aude
Otegbeye, Folashade
Cassaday, Ryan Daniel
Milano, Filippo
Maloney, David G.
Gauthier, Jordan
机构：
[1] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7034
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Predicted Fludarabine Exposure Is Independently Associated with CRS and ICANS after CD19 CAR T-Cell Therapy
    Huang, Ivan J.
    Yeh, Rosa
    Sweiss, Karen
    Patel, Pritesh
    Hirayama, Alexandre Vinaud
    Kimble, Erik L.
    Juluri, Krishna R.
    Shadman, Mazyar
    Turtle, Cameron J.
    Maloney, David G.
    Gauthier, Jordan
    BLOOD, 2022, 140 : 12725 - 12727
  • [2] Aggressive Lymphoma after CD19 CAR T-Cell Therapy
    Kobbe, Guido
    Bruggemann, Monika
    Baermann, Ben-Niklas
    Wiegand, Laura
    Trautmann, Heiko
    Yousefian, Schayan
    Libertini, Silvana
    Menssen, Hans D.
    Maier, Harald J.
    Ulrich, Peter
    Gao, Jingbo
    Bruch, Peter-Martin
    Liebers, Nora
    Radujkovic, Aleksandar
    Seifert, Marc
    Schniederjohann, Christina
    Paramasivam, Nagarajan
    Fitzgerald, Donnacha
    Seidel, Maximilian
    Esposito, Irene
    Germing, Ulrich
    Cadeddu, Ron-Patrick
    Nachtkamp, Kathrin
    Jaeger, Paul
    Ulrych, Thomas
    Fischer, Johannes C.
    Rox, Jutta M.
    Giesel, Frederik
    Koch, Raphael
    Antoch, Gerald
    Distler, Joerg H. W.
    Meuth, Sven G.
    Jacobsen, Malte
    Hubschmann, Daniel
    Lu, Junyan
    Iaccarino, Ingram
    Haas, Simon
    Damm, Frederik
    Dietrich, Sascha
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1217 - 1226
  • [3] Secondary malignancy after CD19 CAR T-cell therapy
    Rudek, Loreen Sophie
    Alakus, Hakan
    ONKOLOGIE, 2025, : 504 - 506
  • [4] Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
    Rejeski, Kai
    Burchert, Andreas
    Iacoboni, Gloria
    Sesques, Pierre
    Fransecky, Lars
    Buecklein, Veit
    Trenker, Corinna
    Hernani, Rafael
    Naumann, Ralph
    Schaefer, Jonas
    Blumenberg, Viktoria
    Schmidt, Christian
    Sohlbach, Kristina
    von Bergwelt-Baildon, Michael
    Bachy, Emmanuel
    Barba, Pere
    Subklewe, Marion
    BLOOD ADVANCES, 2022, 6 (16) : 4719 - 4725
  • [5] Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
    Chen, George
    Herr, Megan
    Nowak, Jan
    Ho, Christine
    Almyroudis, Nikolaos
    Attwood, Kristopher
    Bonnewell, John
    Walsh, Marissa
    Segal, Brahm
    Ross, Maureen
    McCarthy, Philip
    Hahn, Theresa
    HAEMATOLOGICA, 2023, 108 (02) : 615 - 620
  • [6] Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell
    Nie, Esther H.
    Su, Yi-Jiun
    Baird, John H.
    Agarwal, Neha
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Smith, Melody
    Dahiya, Saurabh
    Han, May H.
    Dunn, Jeffrey E.
    Kipp, Lucas B.
    Miklos, David B.
    Scott, Brian J.
    Frank, Matthew J.
    BLOOD ADVANCES, 2024, 8 (06) : 1474 - 1486
  • [7] Paving the road ahead for CD19 CAR T-cell therapy
    Nellan, Anandani
    Lee, Daniel W.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 516 - 520
  • [8] Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
    Hsieh, Emily M.
    Myers, Regina M.
    Yates, Bonnie
    Annesley, Colleen
    John, Samuel
    Taraseviciute, Agne
    Steinberg, Seth M.
    Sheppard, Jennifer
    Chung, Perry
    Chen, Lee
    Lee, Daniel W.
    DiNofia, Amanda
    Grupp, Stephan A.
    Verneris, Michael R.
    Laetsch, Theodore W.
    Bhojwani, Deepa
    Brown, Patrick A.
    Pulsipher, Michael A.
    Rheingold, Susan R.
    Gardner, Rebecca A.
    Gore, Lia
    Shah, Nirali N.
    Lamble, Adam J.
    BLOOD ADVANCES, 2022, 6 (17) : 5222 - 5226
  • [9] Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy
    Tang, Kevin
    Khwaja, Raamis
    Feng, Lei
    Strati, Paolo
    Steiner, Raphael E.
    Nair, Ranjit
    Flowers, Christopher R.
    Saini, Neeraj
    Ramdial, Jeremy L.
    Srour, Samer A.
    Champlin, Richard E.
    Rondon, Gabriela
    Torres, Janet
    Kebriaei, Partow
    Nastoupil, Loretta J.
    Mistry, Haleigh
    Shpall, Elizabeth J.
    Nieto, Yago
    Westin, Jason
    Neelapu, Sattva S.
    Ahmed, Sairah
    BLOOD, 2022, 140 : 4684 - 4685
  • [10] Development and Validation of a Clinical Prediction Model for the Efficacy of CD19 CAR T-Cell Therapy in DLBCL
    Xue, Bin
    Luo, Xiu
    Liu, Yifan
    Zhou, Lili
    Ye, Shiguang
    Li, Shaoguang
    Li, Ping
    Liang, Aibin
    BLOOD, 2023, 142
12345